Rakesh Passi, M.D.,
Adolescent Medicine (Internal Medicine) Physician in East Brunswick, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 375 in Adolescent Medicine (Internal Medicine) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Rakesh Passi, M.D., reported a CMS MIPS final score of 75.8/100 - below the 83.5 national average - and filed 18,666 Medicare Part D claims in 2023.
- 75.8/100
- MIPS score · -8 vs avg
- 19K
- Part D claims, 2023
- 85%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1275550915 · Adolescent Medicine (Internal Medicine) Physician
NPI-10 · ENUM-LEGACY · TAX-TRACE · MIPS-BELOW · RX-HEAVY · BOOK-THIN · PHOTO-FINISH
- NPI-10 1275550915
- ENUM-LEGACY 2006
- TAX-TRACE 375
- MIPS-BELOW 75.8/100
- RX-HEAVY 19K claims
- BOOK-THIN 23 in New Jersey
- PHOTO-FINISH Mohinder Vindhyal · ±0.2
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Jessie Copeland …
Jessie Copeland
75 MIPS pts
- Passi · this pro…
Passi · this provider
75.8 MIPS pts
- Mohinder Vindhya…
Mohinder Vindhyal
76 MIPS pts
- Alston Warr · hi…
Alston Warr
76.5 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Rakesh Passi, M.D.,'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
76 ≥ 15th percentile 15% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Rakesh Passi, M.D., sits
This provider among adolescent medicine (internal medicine) physician peers
Across the 61 adolescent medicine (internal medicine) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Rakesh Passi, M.D., writes more Part D claims than 95% of them and scores higher on MIPS quality than 28% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one adolescent medicine (internal medicine) physician peer from a representative sample of 60; the gold marker is Rakesh Passi, M.D.,. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Rakesh Passi, M.D., practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Rakesh Passi, M.D.,?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Jersey
How Adolescent Medicine (Internal Medicine) Physician compares to other specialties among New Jersey providers
Adolescent Medicine (Internal Medicine) Physician ranks #251 among New Jersey's specialties (0% of in-state providers)
Each bar is a specialty's share of the New Jersey provider total, by primary NUCC taxonomy. The highlighted bar is Adolescent Medicine (Internal Medicine) Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Rakesh Passi, M.D.,'s 2023 MIPS final score plotted against the Adolescent Medicine (Internal Medicine) Physician national average
- MIPS Final Score
- 75.8/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Adolescent Medicine (Internal Medicine) Physician US NPIs
75.8/100 MIPS final score - 7.7 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Adolescent Medicine (Internal Medicine) Physician. Quality dim: 68.7. Cost dim: 50.7.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1275550915 |
|---|---|
| Specialty | Adolescent Medicine (Internal Medicine) Physician |
| Credentials | M.D., |
| Gender | Male |
| NPI Issued | 07/17/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Rakesh Passi, M.D.,'s current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1275550915 is the unique 10-digit identifier CMS uses to link Passi across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Rakesh Passi, M.D., bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Rakesh Passi, M.D.,. Source: openpaymentsdata.cms.gov.
Total received
$4.0K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
15% brand-name claims vs 85% generic, on 18,666 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 46,238
- Total Day Supply
- 1,368,813
- Brand vs Generic
- 15% brand / 85% generic
- Brand Drug Cost
- $3.2M
- Generic Drug Cost
- $447K
- Opioid Claims
- 26 (0.1% rate)
- Antibiotic Claims
- 176
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 1.38
- Gender Split
- 50% female / 50% male
- Age Distribution
- <65: 127, 65-74: 763, 75-84: 629, 85+: 147
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Rakesh Passi, M.D., prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
1,346 claims
- Metoprolol Succinate
Metoprolol Succinate
1,113 claims
- Amlodipine Besylate
Amlodipine Besylate
934 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
896 claims
- Metoprolol Tartrate
Metoprolol Tartrate
668 claims
- Losartan Potassium
Losartan Potassium
599 claims
- Metformin Hcl 535
Metformin Hcl
535 claims
- Furosemide 527
Furosemide
527 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 1,346 |
| Metoprolol Succinate | 1,113 |
| Amlodipine Besylate | 934 |
| Rosuvastatin Calcium | 896 |
| Metoprolol Tartrate | 668 |
| Losartan Potassium | 599 |
| Metformin Hcl | 535 |
| Furosemide | 527 |
| Eliquis Apixaban | 479 |
| Clopidogrel Clopidogrel Bisulfate | 426 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Adolescent Medicine (Internal Medicine) Physician Overview
How Rakesh Passi, M.D., fits within the Adolescent Medicine (Internal Medicine) Physician landscape nationally.
Rakesh Passi, M.D.,'s 18,666 claims are above the specialty average of 3,242.
Nationwide Adolescent Medicine (Internal Medicine) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Passi, both outside New Jersey so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75.8 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Adolescent Medicine (Internal Medicine) Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Passi.
One of 23 Adolescent Medicine (Internal Medicine) Physician providers enrolled in New Jersey, 5 are shown here.
Frequently Asked Questions
What is Rakesh Passi, M.D.,'s specialty? ▼
How much does Rakesh Passi, M.D., prescribe under Medicare Part D? ▼
What is Rakesh Passi, M.D.,'s Medicare quality score? ▼
Where is Rakesh Passi, M.D., located? ▼
What is Rakesh Passi, M.D.,'s NPI number? ▼
Does Rakesh Passi, M.D., prescribe more brand-name or generic drugs? ▼
Does Rakesh Passi, M.D., prescribe opioids? ▼
How many Adolescent Medicine (Internal Medicine) Physician providers are there in the US? ▼
What drugs does Rakesh Passi, M.D., prescribe most often? ▼
Does Rakesh Passi, M.D., accept Medicare? ▼
How can I verify Rakesh Passi, M.D.,'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.